KU Leuven: Lung Diseases trials
The registry lists 16 Lung Diseases studies with KU Leuven as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 4 2No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Enhancing Physical Activity in Patients With Interstitial Lung DiseaseCompletedNCT04138173Not applicable
- Endoscopic Long Volume Reduction by Endobronchial Valves in BelgiumStatus unknownNCT03264768Not applicable
- Diagnostic Value of Transbronchial Lung CryobiopsyStatus unknownNCT02579304
- Systematic Approach for the Diagnosis and Treatment of Obstructive Lung DiseasesStatus unknownNCT02488590
- Falling in Patients With COPD Referred to Pulmonary Rehabilitation: Incidence, Risk Factors and Prediction ToolsStatus unknownNCT02434198
- Innovation in Endobronchial SamplingStatus unknownNCT02380326
- Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02186340Not applicable
- Impact of "Telecoaching Program" on Physical Activity in Patients With COPDCompletedNCT02158065Not applicable
- Downhill Walking Training in COPDStatus unknownNCT02113748Not applicable
- Proprioceptive Postural Control and Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01505543
- Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!Status unknownNCT01314807
- Adherence to Medication and Its Impact on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: The AMICE Prospective StudyStatus unknownNCT01293890
- Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant RecipientsCompletedNCT01204970
- Pulmonary Rehabilitation in Interstitial Lung DiseasesCompletedNCT00882817Phase 4
- Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung CancerStatus unknownNCT00858520
- Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00666367Phase 4